Ras pathway inhibition prevents neovascularization by repressing endothelial cell sprouting
Open Access
- 1 October 2013
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 123 (11), 4900-4908
- https://doi.org/10.1172/jci70230
Abstract
Vascular networks develop from a growing vascular front that responds to VEGF and other guidance cues. Angiogenesis is required for normal tissue function, but, under conditions of stress, inappropriate vascularization can lead to disease. Therefore, inhibition of angiogenic sprouting may prevent neovascularization in patients with blinding neovascular eye diseases, including macular degeneration. VEGF antagonists have therapeutic benefits but also can elicit off-target effects. Here, we found that the Ras pathway, which functions downstream of a wide range of cytokines including VEGF, is active in the growing vascular front of developing and pathological vascular networks. The endogenous Ras inhibitor p120RasGAP was expressed predominately in quiescent VEGF-insensitive endothelial cells and was ectopically downregulated in multiple neovascular models. MicroRNA-132 negatively regulated p120RasGAP expression. Experimental delivery of α-miR-132 to developing mouse eyes disrupted tip cell Ras activity and prevented angiogenic sprouting. This strategy prevented ocular neovascularization in multiple rodent models even more potently than the VEGF antagonist, VEGF-trap. Targeting microRNA-132 as a therapeutic strategy may prove useful for treating multiple neovascular diseases of the eye and for preventing vision loss regardless of the neovascular stimulus.This publication has 38 references indexed in Scilit:
- Simple piggyBac transposon-based mammalian cell expression system for inducible protein productionProceedings of the National Academy of Sciences of the United States of America, 2013
- Double Anti-angiogenic and Anti-inflammatory Protein Valpha Targeting VEGF-A and TNF-α in Retinopathy and PsoriasisOnline Journal of Public Health Informatics, 2011
- MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesisNature Medicine, 2010
- Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retinaGlia, 2010
- An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillarisProceedings of the National Academy of Sciences of the United States of America, 2009
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- VEGF Inhibition and Renal Thrombotic MicroangiopathyThe New England Journal of Medicine, 2008
- The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branchingProceedings of the National Academy of Sciences of the United States of America, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Combination angiostatic therapy completely inhibits ocular and tumor angiogenesisProceedings of the National Academy of Sciences of the United States of America, 2007